Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Study Completion Date

2006-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-centre, open, parallel-group study with three age groups; no study medication or intervention will be provided. This is a longitudinal follow-up of physiological parameters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Thromboelastogram in Postdelivery Preeclamptic Patients

NCT03555630

Preeclampsia Coagulation Disorder Pregnancy Complications

COMPLETED

The Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery Reactivity

NCT03888170

Pregnancy Preeclampsia Hypertension in Pregnancy

WITHDRAWN

Hemodynamic Changes During Normal Pregnancy

NCT00682201

Pregnancy

COMPLETED

Uterine Artery Diastolic Notching & Apelin-13 and 36

NCT06390202

Diagnosis

COMPLETED

A Study of Pregnancy Outcomes in Congenital Heart Disease

NCT06678256

Congenital Heart Disease

SUSPENDED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The subjects will be investigated as outpatients. For each subject, 4 individual dates with a duration of approximately 30 minutes each are scheduled - at the end of the first trimenon, at the end of the second trimenon, 4 weeks prior to the calculated date of birth, and 6 weeks after the effective date of birth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Trimester, First Pregnancy Trimester, Second Pregnancy Trimester, Third

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

20 to 22 years

No interventions assigned to this group

2

30 to 32 years

No interventions assigned to this group

3

40 to 42 years

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women without major concomitant disease
* Willing and able to provide informed consent
* Age (three age groups):

* 20 to 22 years
* 30 to 32 years
* 40 to 42 years

* Major concomitant disease